| GSK2656157 |
GSK2656157 |
1337532-29-2 |
| CEP-32496 (free base) |
CEP 32496 |
1188910-76-0 |
| (S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate |
(S)-(+)-2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-基)乙酸叔丁酯 |
1268524-70-4 |
| 2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid |
2-[[(1R)-1-[7-甲基-2-(4-吗啉)-4-氧代-4H-吡啶并[1,2-A]嘧啶-9-基]乙基]氨基]苯甲酸 |
1173900-33-8 |
| AZ20 |
AZ20 |
1233339-22-4 |
| CCT 137690 |
甲磺酸阿贝西尼 |
1095382-05-0 |
| 1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
PP121 |
1092788-83-4 |
| GSK1904529A |
N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶基]咪唑并[1,2-A]吡啶-2-基]-2-甲氧基苯甲酰胺 |
1089283-49-7 |
| 4-[6-[4-(1-Methylethoxy)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline |
DMH1 |
1206711-16-1 |
| AZD2461 |
4-[4-氟-3-[(4-甲氧基哌啶-1-基)羰基]苄基]酞嗪-1(2H)-酮 |
1174043-16-3 |
| A66 |
A66 |
1166227-08-2 |
| b-AP15 |
b-AP15 |
1009817-63-3 |
| IM-12 |
IM-12 |
1129669-05-1 |
| LDN-193189 |
LDN-193189 |
1062368-24-4 |
| 5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a] |
(ML347) |
1062368-49-3 |
| GNF 5837 |
GNF 5837 |
1033769-28-6 |
| Ceritinib (LDK378) |
色瑞替尼 |
1032900-25-6 |
| IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea |
PQ 401 |
196868-63-0 |
| DBeQ |
DBEQ |
177355-84-9 |
| Pyraclostrobin |
吡唑醚菌酯 |
175013-18-0 |
